INTRODUCTION {#s1}
============

Although the incidence of gastric cancer has been substantially declining for several decades, it remains a major cause of cancer mortality because of its poor prognosis \[[@R1]\]. Complete resection remains the only treatment that can lead to cure for gastric cancer and the presence or absence of lymph node (LN) metastasis was widely considered to be the most important predictor for gastric cancer survival, and LN-negative patients have been shown to have better survival than those with LN metastasis \[[@R2], [@R3]\]. However, patients with node-negative gastric cancer also experience recurrences and may have fatal outcomes \[[@R2], [@R4], [@R5]\]. For such reasons, many researchers make efforts to investigate the prognostic factors related to recurrence and survival.

The tumor-node-metastasis (TNM) classification of the Union for International Cancer Control (UICC) for gastric cancer is considered as the best classification system because of its ability to provide precise prognostic estimation and guidance for patients through appropriate therapeutic programs. Currently, the 7th edition TNM classification is most widely used for the staging of gastric cancer, but it does not define the minimum number of retrieved LNs necessary, especially for the gastric cancer patients with no LNs metastasis. Some previously published articles sought to investigate the prognostic value of LNs retrieval in node-negative gastric cancer, but the number of patients included in their study was small \[[@R6], [@R7]\], and the cutoff used in the study may also be arbitrary.

The objective of this study was to investigate prognosis value of retrieved LNs count and other clinical pathologic characteristics in patients who had no LNs metastasis, and to find a reasonable retrieved LNs cutoff value that guarantee accurate TNM stage. In order to get convincing results in a larger series patients, we using SEER (Surveillance, Epidemiology and End Results)-registered database to analyze and X-tile program \[[@R8]\] to determine the optimal cutoff.

RESULTS {#s2}
=======

Patient characteristics {#s2_1}
-----------------------

Of the 5,794 patients (62.2% male, 37.8% female) with LN negative gastric cancer who met the eligibility criteria, 4,670 (80.26%) were diagnosed as adenocarcinoma, 907 (15.65%) as signet ring cell carcinoma, and 217 (3.75%) as mucinous adenocarcinoma. Most patients (65.9%) were white, and nearly half patients (50.7%) had poor- or undifferentiated tumors. Patients\' demographics and pathological features are summarized in Table [1](#T1){ref-type="table"}.

###### Demographic and tumor characteristics of patients with node negative gastric cancer

                                                      LNs Subgroup   χ^2^ Value    *P* Value                                                                                 
  --------------------------------------------------- -------------- ------------- ------------- ------- ------------------------------------------------- ------- --------- ----------
  Characteristic                                      No.            \%            No.           \%      No.                                               \%                
  Sex                                                                                                                                                              3.560     0.169
   male                                               590            63.9%         1466          62.9%   1545                                              60.9%             
   female                                             333            36.1%         866           37.1%   994                                               39.1%             
  Age                                                 72 (62--80)    70 (60--78)   66 (57--75)           \< 0.001[^\*\*^](#tfn_002){ref-type="table-fn"}                     
  Race                                                                                                                                                             31.777    \< 0.001
   Caucasian                                          624            67.6%         1600          68.6%   1596                                              62.9%             
   Black                                              120            13.0%         262           11.2%   282                                               11.2%             
   Other[^\*^](#tfn_001){ref-type="table-fn"}         179            19.4%         470           20.2%   659                                               26.0%             
  Married staus                                                                                                                                                              
   Married                                            541            58.6%         1444          61.9%   1653                                              65.1%             
   Unmarried                                          347            37.6%         816           35.0%   791                                               31.2%             
   Unknown                                            35             3.8%          72            3.1%    95                                                3.7%              
  Pathological grading                                                                                                                                             12.562    0.014
   High/Moderate                                      433            47.0%         1000          42.9%   1056                                              41.6%             
   Poor/Anaplastic                                    421            45.6%         1190          51.0%   1327                                              52.3%             
   Unknown                                            68             7.4%          142           6.1%    156                                               6.1%              
  Histotype                                                                                                                                                        2.093     0.351
   Adenocarcinoma                                     748            80.7%         1899          81.4%   2026                                              79.8%             
  Mucinous/Signet ring cell                           178            19.3%         554           18.6%   513                                               20.2%             
  Tumor size (mm)                                                                                                                                                  103.516   \< 0.001
   \< = 20                                            323            35.0%         765           32.8%   731                                               28.9%             
   20--50                                             321            34.8%         891           38.2%   908                                               35.8%             
   \> 50                                              112            12.1%         371           15.9%   607                                               23.9%             
  Unknown                                             167            18.1%         305           13.1%   290                                               13.1%             
  Stage                                                                                                                                                            26.923    \< 0.001
   I                                                  608            65.9%         1499          64.3%   1521                                              59.9%             
   II                                                 274            29.7%         766           32.8%   943                                               37.1%             
   III                                                38             4.1%          56            2.4%    67                                                2.6%              
   Unknown[^\*\*\*^](#tfn_003){ref-type="table-fn"}   3              0.3%          11            0.5%    8                                                 0.3%              

Other includes American Indian/Alaska native, Asian/Pacific Islander, and unknown.

Mann-Whitney *U* test.

Unknown: undefined T stage.

All patients had at least one LN examined. The median number of LNs examined was 12 (IQR 7--19). The 5-year cause specific survival (CSS) was 74.0%. X-tile plots were constructed and the maximum of χ^2^ log-rank value of 72.026 was achieved when applying 4 and 13 as the cutoff values of retrieved LN number. Patients can be accordingly divided into the high, middle and the low subsets in terms of 5-year CSS, which were 64.8%, 72.5% and 79.4%, respectively (*P* \< 0.001, Figure [1](#F1){ref-type="fig"}).

![X-tile analysis of survival data from the SEER registry\
X-tile analysis was performed using data from SEER database. The sample of patients with gastric cancer was equally divided into training and validation sets. X-tile plots of the training sets are shown in the *left panels*, with plots of matched validation sets shown in the *smaller inset*. The optimal cut-point highlighted by the *black circle* in the *left panels* is shown on a histogram of the entire cohort (*middle panels*), and a Kaplan-Meier plot (*right panels*). *P* values were determined using the cutoff point defined in the training set and applying it to the validation set. *Figure [1](#F1){ref-type="fig"}* shows the optimal cutoff points for the lymph node negative patients (number of 4 and 13, χ^2^ = 72.026, *P* \< 0.001).](oncotarget-07-43680-g001){#F1}

Impact of total number of LNs examined on risk of death {#s2_2}
-------------------------------------------------------

Using Kaplan-Meier estimates, beside of the number of retrieved LNs, some other clinicopathological factors, including age (*P* \< 0.001), race (*P* \< 0.001), pathological grade (*P* \< 0.001), tumor size (*P* \< 0.001), and T stage (*P* \< 0.001) were also found to be risk factors for CSS.

Further multivariate analysis showed that all six factors were associated with survival (Table [2](#T2){ref-type="table"}). Elder patients (HR 0.90, 95% CI 0.87 to 0.93) had 1.593--fold increase in the risk of death. Non-Caucasian/Black patients (referent, Caucasian patients: HR 0.740, 95% CI 0.631--0.869) had an improved overall survival. Patients with poor/anaplastic tumor grade had a worse prognosis compared with tumors with high/moderate differentiation (HR: 1.380, 95%CI 1.219 to 1.564, high/moderate differentiation as reference). Patients with a T2 tumor had a 1.495-fold increase in the risk of death (HR 1.495; 95% CI 1.223 to 1.828); patients with T3 tumors had 2.770-fold increased risk (HR 2.770; 95% CI 2.341--3.277); T4a tumor had 3.731-fold increased risk (HR 3.731; 95% CI 3.058--4.553); and T4b tumor had 5.619-fold increased risk (HR5.619; 95% CI 4.324--7.302, T1 stage as reference). Tumor size was associated with survival as well (20 to 50 mm, HR 1.240; 95% CI 1.042--1.476; \>50 mm, HR 1.402; 95% CI 1.154--1.703; \<20 mm as reference). As anticipated, increasing LNs retrieval was associated with improved survival (5--13, HR 0.684, 95% CI 0.589--0.794; \> 13, HR 0.501, 95% CI 0.428--0.587; 1--4 as referenced).

###### Univariate and multivariate survival analyses for evaluating the influence of the number of LNs retrieved on CSS in node negative gastric cancer

  Variable                     5-year RCCS   Univariate analysis   Multivariate analysis                          
  ---------------------------- ------------- --------------------- ----------------------- ---------------------- ----------
  Sex                                        1.864                 0.172                                          NI
   Male                        73.1%                                                                              
   Female                      75.8%                                                                              
  Age                                        37.652                \< 0.001                                       \< 0.001
   ≤ 60                        79.1%                                                       Reference              
   \> 60                       72.0%                                                       1.593 (1.383--1.834)   
  Race                                       34.396                \< 0.001                                       0.001
   Caucasian                   71.3%                                                       Reference              
   Black                       75.8%                                                       0.918 (0.763--1.104)   0.362
   Others                      81.3%                                                       0.740 (0.631--0.869)   \< 0.001
  Grade                                      57.923                \< 0.001                                       \< 0.001
   High/Moderate               78.8%                                                       Reference              
   Poor/Anaplastic             69.3%                                                       1.380 (1.219--1.564)   \< 0.001
   Unknown                     81.0%                                                       0.995 (0.745--1.330)   0.974
  Histotype                                  3.390                 0.066                                          NI
   Adenocarcinoma              74.8%                                                                              
   Mucinous/signet ring cell   71.4%                                                                              
  Tumor size (mm)                            149.109               \< 0.001                                       0.007
   \< 20                       84.4%                                                       Reference              
   20--50                      70.9%                                                       1.240 (1.042--1.476)   0.015
   \> 50                       62.9%                                                       1.402 (1.154--1.703)   0.001
  Unknown                      74.4%                                                       1.295 (1.048--1.599)   0.016
  T Stage                                    511.603               \< 0.001                                       \< 0.001
   T1                          86.3%                                                       Reference              
   T2                          78.5%                                                       1.495 (1.223--1.828)   \< 0.001
   T3                          61.4%                                                       2.770 (2.341--3.277)   \< 0.001
   T4a                         52.2%                                                       3.731 (3.058--4.553)   \< 0.001
   T4b                         41.2%                                                       5.619 (4.324--7.302)   \< 0.001
   Tx                          26.1%                                                       4.941 (2.812--8.680)   \< 0.001
  No. of LNs                                 72.026                \< 0.001                                       \< 0.001
   1--4                        64.8%                                                       Reference              
   5--13                       72.5%                                                       0.684 (0.589--0.794)   \< 0.001
   \> 13                       79.4%                                                       0.501 (0.428--0.587)   \< 0.001

NI: not included in the multivariate survival analysis.

The Cox model performance was composed of two components, discrimination and calibration. The ability of a model to separate subject outcomes is known as discrimination. Discrimination was quantified with the Harrell\'s concordance index (C-index), which is similar with the area under the receiver operating characteristic (ROC) curve but appropriate for censored data. As shown in Table [2](#T2){ref-type="table"}, the C-index of Cox model is 0.703 (95% CI: 0.672--0.734). Calibration was performed by comparing predicted probability of CSS versus actual CSS on the 5,794 patients. The calibration curves for the probabilities of 3- and 5-year CSS showed excellent agreement of the nomogram prediction with actual observation as demonstrated in Figure [2](#F2){ref-type="fig"}.

![Nomogram for predicting 3- and 5-year cause specific survival (CSS) of gastric cancer patients\
(**A**) Using nomograms with clinicopathological characteristics are shown. Instructions for use of the nomogram: First, assign the points of each characteristic of the patient by drawing a vertical line from that variable to the points scale. Then, sum all the points and draw a vertical line from the total points scale to the 3- and 5-year CSS to obtain the probability of death. (**B**) The reference line is 45 degree and indicates perfect calibration.](oncotarget-07-43680-g002){#F2}

Identification of minimum number of retrieved LNs {#s2_3}
-------------------------------------------------

To assess the influence of different cutoff points on gastric cancer CSS, we further analyzed the number of retrieved LN counts from 2 to 22. The 5-year CSS of patients with *n* (cutoff point) or more nodes and less than *n* nodes were calculated, respectively. The survival rate of patients with *n* or more nodes increased gradually when *n* ranged from 2 to 14. Patients with 14 or more LNs evaluated had a relative reduction of 16.9% for death from gastric cancer compared to those with two less LNs evaluated (79.4% versus 62.5%). After the number of 14, the survival rates were roughly equal (Table [3](#T3){ref-type="table"}). It is likely that 14 is the minimum number of LNs that should be retrieved, above which the influence of negative LNs (NLNs) count on survival is minimal.

###### Univariate analysis for the influence of different cutoffs on CSS in node-negative gastric cancer

  Cutoff   No.    5-year CCS   Log-rank χ^2^   *P* value
  -------- ------ ------------ --------------- -----------
  \< 2     204    62.5%        16.291          \< 0.001
  ≥ 2      5590   74.5%                        
  \< 3     544    63.7%        31.843          \< 0.001
  ≥ 3      5339   75.0%                        
  \< 4     674    63.9%        49.099          \< 0.001
  ≥ 4      5120   75.5%                        
  \< 5     923    64.8%        55.491          \< 0.001
  ≥ 5      4871   75.9%                        
  \< 6     1165   66.3%        50.457          \< 0.001
  ≥ 6      4629   76.2%                        
  \< 7     1447   65.9%        64.626          \< 0.001
  ≥ 7      4347   77.1%                        
  \< 8     1704   66.6%        64.600          \< 0.001
  ≥ 8      4090   77.5%                        
  \< 9     1990   67.9%        40.856          \< 0.001
  ≥ 9      3804   77.6%                        
  \< 10    2271   68.3%        52.554          \< 0.001
  ≥ 10     3523   78.1%                        
  \< 11    2517   69.3%        45.706          \< 0.001
  ≥ 11     3277   78.0%                        
  \< 12    2752   70.0%        39.887          \< 0.001
  ≥ 12     3042   78.2%                        
  \< 13    3005   70.0%        26.407          \< 0.001
  ≥ 13     2789   78.7%                        
  \< 14    3255   70.3%        17.277          \< 0.001
  ≥ 14     2539   79.4%                        
  \< 15    3459   71.0%        34.280          \< 0.001
  ≥ 15     2335   79.1%                        
  \< 16    3664   71.3%        31.059          \< 0.001
  ≥ 16     2130   79.2%                        
  \< 17    3778   71.4%        32.499          \< 0.001
  ≥ 17     1916   79.9%                        
  \< 18    4071   71.9%        24.916          \< 0.001
  ≥ 18     1723   79.6%                        
  \< 19    4237   72.3%        32.499          \< 0.001
  ≥ 19     1557   79.2%                        
  \< 20    4372   71.9%        24.916          \< 0.001
  ≥ 20     1422   79.4%                        
  \< 21    4531   72.7%        24.916          \< 0.001
  ≥ 21     1263   79.4%                        
  \< 22    4531   72.8%        13.907          \< 0.001
  ≥ 22     1263   79.5%                        

DISCUSSION {#s3}
==========

Previously, several studies investigated the prognostic factors for node-negative gastric adenocarcinoma with R0 resection. In contrast to previous studies, we first used X-tile program to divided patients into high, middle, and low risk groups, and validated retrieved LNs count was an independent prognostic factor in node-negative gastric cancer. Then, in order to find minimum number of LNs that should be retrieved, we analyzed individual LN counts from 2 to 22 and found number of 14 met the criteria. After the number of 14, the 5-year CSS the survival rates were roughly equal. In addition, to the best of our knowledge, our study is the largest scaled one that assess lymph node count on prognosis in node-negative gastric cancer.

Compared with node-positive gastric cancer, node-negative tumors have less aggressive biological features and a more favorable prognosis \[[@R2], [@R6], [@R9]\]. However, patients with node-negative gastric cancer also experience recurrences \[[@R4], [@R10]\]. Identifying the risk factors associated with the recurrence of node-negative gastric cancer is important because these patients are assured to undergo radical resection and not have any microscopic regional metastases. LN retrieval is an independent risk factor for tumor recurrence and a poor prognostic factor in various cancer undergoing radical resection \[[@R11]--[@R14]\]. In the present study, we also found that the survival rates increased as the number of retrieved LN counts increased. There was 14.9% increase in 5-year CSS if ≥ 14 LN was retrieved compared with those with \< 2 LN retrieved. Despite this correlation, the mechanism underlying the relationship between the number of LNs and survival has not been determined, although several hypotheses have been proposed.

The first hypothesis involves stage-migration. The isolated tumor cells and micrometastasis in negative LNs are considered as the key factors that could lead to the adverse effect on the overall survival of gastric cancer patients \[[@R15]--[@R17]\]. Harrison *et al*. demonstrated that patients with T3N0M0 gastric cancer who underwent extended lymphadenectomy had significantly more negative LNs than those who underwent limited lymphadenectomy, thereby indicating that extended lymphadenectomy can improve the overall survival of T3N0M0 patients. This result is potentially associated with the elimination of micrommetastasis in LNs \[[@R18]\]. Increased LNs retrieval will reduce the chance of understaging, and then improve survival.

The second hypothesis regards the function of LNs. It is considered that the immunity exerted by tumor-draining LNs is dual function for cancer cells, namely antitumor immunity and tolerance for cancer. Resection of regional LNs might reset the immunological balance, resulting in an improvement of patients\' prognosis. A higher number of LNs dissected may simply reflect a host lymphocytic reaction to the tumor, which is associated with LN count \[[@R19]\], and lymphocytic reaction to tumor cells has been associated with longer survival in colorectal cancer \[[@R20], [@R21]\].

The second hypothesis revolves around the notion that the surgeon is a technician \[[@R22]\]. In theory, an increasing number of examined LNs indicates a high quality of surgical care. Improved surgical techniques may be the result of improved intraoperative staging \[[@R23]\], and therefore reduce the chances of iatrogenic spread of cancer cells \[[@R22]\]. As such, there is less likelihood of leaving tumor cells behind, thus positively affecting survival. Serosal exposure was an important prognostic factor for node-negative advanced gastric cancer after radical resection \[[@R24]--[@R26]\]. The chance of iatrogenic spread of cancer cells may be high in those patients. High quality of surgery will significantly reduce such adverse effect.

We acknowledge that our study suffers from several shortcomings. First, we only assessed CSS as end point in this study, for there were no information about local recurrence and distance metastasis in SEER database. Second, the SEER database does not include information regarding the administration of chemotherapy and the quality of surgical care or pathological technique, and all of these factors may impact survival outcomes, and we cannot adjust these factors in survival analysis. Third, distant LN metastases always classified as distant metastases and therefore the surgery were regarded as palliative resection, and should be excluded from this study. But for SEER data lacks such information, we cannot adjust for this.

In conclusion, retrieved LNs count was associated with long-time survival outcomes in node-negative gastric cancer. Patients would have a decrease in the risk of death for each additional LN examined up to a total of 14. In light of the association of LNs retrieval with postoperative treatment and prognosis, efforts to improve quality of care in this area could produce substantial improvements in outcome.

MATERIALS AND METHODS {#s4}
=====================

Data was obtained from the current SEER database (Surveillance Research Program, National Cancer Institute SEER\*Stat software \[version 8.2.1\], <http://www.seer.cancer.gov/seerstat>) maintained by the National Cancer Institute, which consists of 18 population-based cancer registries. Inclusion criteria included the following: (1) patients were diagnosed from 2004 to 2012; (2) the site code was limited to stomach; (3) histology code was limited to adenocarcinoma (8140/3, 8144/3, 8255/3, 8211/3, 8260/3,8263/3), mucinous adenocarcinoma (8480/3), and signet ring cell carcinoma (8490/3); (4) with no LN metastasis(N0) and distant metastasis(M0); (5) underwent surgical resection; (6) at least with one LN retrieval; (7) age \> 18 years old; (8) gastric cancer was the only one primary or first of more than one primary; (9) information on CSS and survival months available.

Standard patients\' demographic, clinicopathologic data including histological type, tumor grade, T stage, number of LNs retrieval, and number of positive LNs were collected. Among these factors, sex, race, tumor grade, histologic type, T or N stage, primary site and tumor metastatic status were considered categorical variables. Continuous variables including age and retrieved LN count were categorized. We divided the patients into two age groups: \< 60 years old and ≥ 60 years old. Patients were stratified by retrieved LN count into three groups according to cutoffs determined by X-tile program. All patients were restaged according to AJCC/UICC 7th edition.

Statistical analysis {#s4_1}
--------------------

Statistics analysis was carried out using the statistical software package SPSS for Windows, version 21 (IBM Corp, Armonk, NY, USA). The LNs cutoff points were determined using the X-tile program (<http://www.tissuearray.org/rimmlab/>), which identified the cutoff with the minimum *P* values from log-rank χ^2^ statistics for the categorical LNs in terms of survival \[[@R8], [@R27]\]. A comparison of the categorical variables between LNs count subgroups was conducted using Pearson\'s χ^2^ test. Continuous variables were compared using the Mann-Whitney *U* test. To evaluate potential factors affecting survival time, taking survival time and censoring into account, Cox proportional hazards regression was used to report hazard ratio (HR) with 95% confidence intervals.
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